Cannabinoids

A growing number of firms are using genetically engineered yeast to biosynthesize cannabinoids by effectively reverse engineering how Cannabis sativa plants make these molecules (picture: Demetrix)

Demetrix begins demo scale production of rare cannabinoid CBG

By Elaine Watson

Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production of CBG (cannabigerol), the first rare cannabinoid...

Getty Images

Weighing the risks of CBD in sports nutrition

By Danielle Masterson

As cannabis legalization spreads across the country, professional sports leagues are updating their policies, while some players update their portfolios.

NutraCast Podcast: Patrick McCarthy on CBD research and regulation

NutraCast Podcast: Patrick McCarthy on CBD research and regulation

By Danielle Masterson

In recent months the FDA has been trying to figure out how to get the CBD market under control, with the focus on safety. Patrick McCarthy, CEO of Validcare, a cannabis sector-focused health and wellness research company, said the FDA is not going to...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers